Abstract:Background and aims: Hepatocellular carcinoma (HCC), which is prevalent worldwide and has a high mortality rate, needs to be effectively diagnosed. We aimed to evaluate the significance of plasma microRNA-15a/16-1 (miR-15a/16) as a biomarker of hepatitis B virus-related HCC (HBV-HCC) using the machine learning model. This study was the first large-scale investigation of these two miRNAs in HCC plasma samples. Methods: Using quantitative polymerase chain reaction, we measured the plasma miR-15a/16 levels in a total of 766 participants, including 74 healthy controls, 335 with chronic hepatitis B (CHB), 47 with compensated liver cirrhosis, and 310 with HBV-HCC. The diagnostic performance of miR-15a/16 was examined using a machine learning model and compared with that of alpha-fetoprotein (AFP). Lastly, to validate the diagnostic efficiency of miR-15a/16, we performed pseudotemporal sorting of the samples to simulate progression from CHB to HCC. Results: Plasma miR-15a/16 was significantly decreased in HCC than in all control groups (P < 0.05 for all). In the training cohort, the area under the receiver operating characteristic curve (AUC), sensitivity, and average precision (AP) for the detection of HCC were higher for miR-15a (AUC = 0.80, 67.3%, AP = 0.80) and miR-16 (AUC = 0.83, 79.0%, AP = 0.83) than for AFP (AUC = 0.74, 61.7%, AP = 0.72). Combining miR-15a/16 with AFP increased the AUC to 0.86 (sensitivity 85.9%) and the AP to 0.85 and was significantly superior to the other markers in this study (P < 0.05 for all), as further demonstrated by the detection error tradeoff curves. Moreover, miR-15a/16 impressively showed potent diagnostic power in early-stage, small-tumor, and AFP-negative HCC. A validation cohort confirmed these results. Lastly, the simulated follow-up of patients further validated the diagnostic efficiency of miR-15a/16. Conclusions: We developed and validated a plasma miR-15a/16-based machine learning model, which exhibited better diagnostic performance for the early diagnosis of HCC compared to that of AFP. (c) 2024 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Early Diagnosis of Hepatocellular Carcinoma Using Machine Learning Method

Deep Learning-Based Radiomics Models for Early Recurrence Prediction of Hepatocellular Carcinoma with Multi-phase CT Images and Clinical Data.

Development of machine learning-based predictors for early diagnosis of hepatocellular carcinoma

Classification and Prognosis Prediction from Histopathological Images of Hepatocellular Carcinoma by a Fully Automated Pipeline Based on Machine Learning

Construction of immune-related molecular diagnostic and predictive models of hepatocellular carcinoma based on machine learning

A Systems Biology-Based Classifier for Hepatocellular Carcinoma Diagnosis

Construction of diagnostic models for the progression of hepatocellular carcinoma using machine learning

Establishment of diagnostic model and identification of diagnostic markers between liver cancer and cirrhosis based on multi-chip and machine learning

Five Critical Gene-Based Biomarkers with Optimal Performance for Hepatocellular Carcinoma.

Construction of a diagnostic model for hepatitis B-related hepatocellular carcinoma using machine learning and artificial neural networks and revealing the correlation by immunoassay

Identification of a novel gene signature for the prediction of recurrence in HCC patients by machine learning of genome-wide databases

Machine Learning-Enabled Early Detection of Hepatocellular Carcinoma Utilizing Cell-Free DNA Mutation and Fragmentation Multiplicity: a Prospective Study

Preoperative prediction for early recurrence of hepatocellular carcinoma using machine learning-based radiomics

Early Diagnosis of Pancreatic Ductal Adenocarcinoma by Combining Relative Expression Orderings with Machine-Learning Method

Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches

WGCNA combined with machine learning to find potential biomarkers of liver cancer

A Blood-Based 22-Gene Expression Signature for Hepatocellular Carcinoma Identification

Development of a Prediction Classifier for the Early Diagnosis of Liver Cancer

Identifying Module Biomarkers Of Hepatocellular Carcinoma From Gene Expression Data

Computed tomography-based radiomics to predict early recurrence of hepatocellular carcinoma post-hepatectomy in patients background on cirrhosis

Plasma Microrna-15A/16-1-based Machine Learning for Early Detection of Hepatitis B Virus-Related Hepatocellular Carcinoma